Development and validation of a risk stratification model for cardiovascular disease in patients with radiographic axial spondyloarthritis (r-axSpA): a retrospective study - Takeaways - MDSpire

Development and validation of a risk stratification model for cardiovascular disease in patients with radiographic axial spondyloarthritis (r-axSpA): a retrospective study

  • By

  • Ting Tan

  • Minglun Xiao

  • Liang Zhou

  • Zhongqun Wen

  • Xinyi Hu

  • Yuanjun Zheng

  • Zeyan Peng

  • June 8, 2026

  • 0 min

Share

  • 1

    A risk assessment model for cardiovascular disease (CVD) in radiographic axial spondyloarthritis (r-axSpA) patients was developed using routine clinical variables.

  • 2

    The study identified four independent predictors of CVD risk: age, hypertension, diabetes mellitus, and alkaline phosphatase (ALP) levels.

  • 3

    The model demonstrated excellent discriminative ability in the training set with an AUC of 0.888 and acceptable performance in the validation set with an AUC of 0.741.

  • 4

    Calibration of the model was satisfactory, indicated by a Brier score of 0.115, and decision curve analysis confirmed its clinical utility.

  • 5

    External validation in prospective cohorts is necessary before the clinical implementation of this CVD risk stratification tool for r-axSpA patients.

Original Source(s)

Related Content